90 filings
25-NSE
CDAKQ
Codiak BioSciences, Inc.
2 May 23
Exchange delisting
1:35pm
NT 10-K
CDAKQ
Codiak BioSciences, Inc.
28 Mar 23
Notice of late annual filing
7:34pm
8-K
CDAKQ
Codiak BioSciences, Inc.
28 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:28pm
8-K
CDAKQ
Codiak BioSciences, Inc.
27 Mar 23
Bankruptcy or Receivership
9:59am
10-Q
2022 Q3
CDAKQ
Codiak BioSciences, Inc.
Quarterly report
3 Nov 22
4:14pm
8-K
yp7 nfrrt7
3 Nov 22
Codiak BioSciences Reports Third Quarter 2022 Financial Results and Third Quarter 2022 and Recent Highlights
4:11pm
8-K
xzjn 34c4vc
13 Sep 22
Codiak Announces Proposed Public Offering of Common Stock and Warrants
8:38pm
424B5
gp6t02h
13 Sep 22
Prospectus supplement for primary offering
8:35pm
424B5
pnqvoi6i18lr
12 Sep 22
Prospectus supplement for primary offering
4:16pm
8-K
mig9e dp5hbx3vd
30 Aug 22
Codiak BioSciences Announces Program Reprioritization and Corporate Restructuring
9:19am
8-K
lnptm4u5uheplyc
4 Aug 22
Codiak BioSciences Reports Second Quarter 2022 Financial Results and Second Quarter 2022 and Recent Highlights
4:07pm
8-K
oufykzqi5o gt9o66
30 Jun 22
Codiak Provides Platform-Validating Clinical Update and Data from Phase 1 Trials
6:36am
8-K
9kx4 nvf704
29 Jun 22
Other Events
8:08am
8-K
kzoxf
21 Jun 22
Submission of Matters to a Vote of Security Holders
4:37pm
8-K
tbzgi3v vcurzakleup
5 May 22
Codiak BioSciences Reports First Quarter 2022 Financial Results and Operational Progress
12:00am
DEFA14A
s1gw xwkimkx5af
29 Apr 22
Additional proxy soliciting materials
12:00am
S-8
tkvg01cfj42z41tkf35
10 Mar 22
Registration of securities for employees
4:46pm